Delayed cerebral ischemia (DCI) is a severe complication of subarachnoid hemorrhage (SAH). Clinical and radiographic features of SAH may be helpful in identification of individuals prone to DCI. The aim of this systematic review was to analyze the present evidence on predictive value of blood and cerebrospinal fluid (CSF) biomarkers of DCI after SAH. We systematically searched in PubMed, Scopus, Web of Science, and Cochrane Library databases for publications before July 15, 2018, reporting correlations between blood/CSF biomarkers and occurrence of DCI and/or vasospasm in SAH patients. Included studies underwent quality assessment according to QUIPS and STARD guidelines. Level of evidence (I–IV) for each of tested biomarkers was assessed according to GRADE guidelines. Of 2181 unique records identified in four databases, 270 original articles and 5 meta-analyses were included to this review. Of 257 blood and CSF parameters analyzed in 16.914 SAH patients, there was no biomarker with positive association with DCI/vasospasm showing level I evidence. Twenty-one biomarkers achieved level II evidence and could be confirmed as predictive biomarkers. In this review, six single nucleotide polymorphisms (for EET metabolic pathways, COMT, HMGB1, ACE, PAI-1 promoter, and Hp genes) and 15 non-genetic biomarkers (pNF-H, ADAMTS13, NPY, Copeptin, HMGB1, GFAP, periostin, Tau, BNP, NT pro-BNP, hs-TnT, PA-TEGMA, MPV:PLT, NLR, and PLR) were selected as predictive DCI biomarkers. We propose that a panel analysis of the selected genetic and protein biomarker candidates would be needed for further validation in a large SAH cohort.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bacigaluppi S, Zona G, Secci F, Spena G, Mavilio N, Brusa G, Agid R, Krings T, Ottonello G, Fontanella M (2015) Diagnosis of cerebral vasospasm and risk of delayed cerebral ischemia related to aneurysmal subarachnoid haemorrhage: an overview of available tools. Neurosurg Rev 38:603–618. https://doi.org/10.1007/s10143-015-0617-3
Burrell C, Avalon NE, Siegel J, Pizzi M, Dutta T, Charlesworth MC, Freeman WD (2016) Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemia. Expert Rev Neurother 16:1251–1262. https://doi.org/10.1080/14737175.2016.1203257
Chen C, Hu Z (2016) ApoE polymorphisms and the risk of different subtypes of stroke in the Chinese population: a comprehensive meta-analysis. Cerebrovasc Dis 41:119–138. https://doi.org/10.1159/000442678
Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, de Vet HC, Bossuyt PM (2016) STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open 6:e012799. https://doi.org/10.1136/bmjopen-2016-012799
D'Souza S (2015) Aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 27:222–240. https://doi.org/10.1097/ANA.0000000000000130
de Oliveira Manoel AL, Jaja BN, Germans MR, Yan H, Qian W, Kouzmina E, Marotta TR, Turkel-Parrella D, Schweizer TA, Macdonald RL, collaborators S (2015) The VASOGRADE: a simple grading scale for prediction of delayed cerebral ischemia after subarachnoid hemorrhage. Stroke 46:1826–1831. https://doi.org/10.1161/STROKEAHA.115.008728
de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ (2013) Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke 44:43–54. https://doi.org/10.1161/STROKEAHA.112.674291
Degos V, Apfel CC, Sanchez P, Colonne C, Renuit I, Clarencon F, Nouet A, Boch AL, Pourmohamad T, Kim H, Gourraud PA, Young WL, Puybasset L (2012) An admission bioclinical score to predict 1-year outcomes in patients undergoing aneurysm coiling. Stroke 43:1253–1259. https://doi.org/10.1161/STROKEAHA.111.638197
DeWitt JC, Mock A, Louis DN (2017) The 2016 WHO classification of central nervous system tumors: what neurologists need to know. Curr Opin Neurol 30:643–649. https://doi.org/10.1097/WCO.0000000000000490
Gallia GL, Tamargo RJ (2006) Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol Res 28:750–758. https://doi.org/10.1179/016164106X152025
Garrido P, Aldaz A, Vera R, Calleja MA, de Alava E, Martin M, Matias-Guiu X, Palacios J (2017) Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH. Clin Transl Oncol 20:443–447. https://doi.org/10.1007/s12094-017-1740-0
Gerber CJ, Lang DA, Neil-Dwyer G, Smith PW (1993) A simple scoring system for accurate prediction of outcome within four days of a subarachnoid haemorrhage. Acta Neurochir 122:11–22
Grasso G, Alafaci C, Macdonald RL (2017) Management of aneurysmal subarachnoid hemorrhage: state of the art and future perspectives. Surg Neurol Int 8:11. https://doi.org/10.4103/2152-7806.198738
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Bmj 336:924–926. https://doi.org/10.1136/bmj.39489.470347.AD
Hanggi D, Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid H (2011) Monitoring and detection of vasospasm II: EEG and invasive monitoring. Neurocrit Care 15:318–323. https://doi.org/10.1007/s12028-011-9583-y
Harrod CG, Bendok BR, Batjer HH (2005) Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 56:633–654 discussion 633-654
Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280–286. https://doi.org/10.7326/0003-4819-158-4-201302190-00009
Jabbarli R, Reinhard M, Roelz R, Shah M, Niesen WD, Kaier K, Taschner C, Weyerbrock A, Van Velthoven V (2015) Early identification of individuals at high risk for cerebral infarction after aneurysmal subarachnoid hemorrhage: the BEHAVIOR score. J Cereb Blood Flow Metab 35:1587–1592. https://doi.org/10.1038/jcbfm.2015.81
Jaja BN, Lingsma H, Schweizer TA, Thorpe KE, Steyerberg EW, Macdonald RL, collaboration S (2015) Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository. J Neurosurg 122:644–652. https://doi.org/10.3171/2014.10.JNS132694
Khurana VG, Fox DJ, Meissner I, Meyer FB, Spetzler RF (2006) Update on evidence for a genetic predisposition to cerebral vasospasm. Neurosurg Focus 21:E3
Kubben PL, Germans MR, Jabbarli R (2017) Delayed cerebral ischemia after subarachnoid hemorrhage: comparing and integrating classification systems. Surg Neurol Int 8:121. https://doi.org/10.4103/2152-7806.208805
Kumar G, Shahripour RB, Harrigan MR (2016) Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg 124:1257–1264. https://doi.org/10.3171/2015.4.JNS15428
Lad SP, Hegen H, Gupta G, Deisenhammer F, Steinberg GK (2012) Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 21:30–41. https://doi.org/10.1016/j.jstrokecerebrovasdis.2010.04.004
Ladner TR, Zuckerman SL, Mocco J (2013) Genetics of cerebral vasospasm. Neurol Res Int 2013:291895–291811. https://doi.org/10.1155/2013/291895
Lanterna LA, Ruigrok Y, Alexander S, Tang J, Biroli F, Dunn LT, Poon WS (2007) Meta-analysis of APOE genotype and subarachnoid hemorrhage: clinical outcome and delayed ischemia. Neurology 69:766–775. https://doi.org/10.1212/01.wnl.0000267640.03300.6b
Laskowitz DT, Grocott H, Hsia A, Copeland KR (1998) Serum markers of cerebral ischemia. J Stroke Cerebrovasc Dis 7:234–241
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097
Neil-Dwyer G, Cruickshank J (1974) The blood leucocyte count and its prognostic significance in subarachnoid haemorrhage. Brain 97:79–86
Roos A, Thompson R, Horvath R, Lochmuller H, Sickmann A (2017) Intersection of proteomics and genomics to “solve the unsolved” in rare disorders such as neurodegenerative and neuromuscular diseases. Proteomics Clin Appl. https://doi.org/10.1002/prca.201700073
Rosalind Lai PM, Du R (2015) Role of genetic polymorphisms in predicting delayed cerebral ischemia and radiographic vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis. World Neurosurg 84:e932. https://doi.org/10.1016/j.wneu.2015.05.070
Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KT (2012) Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth 109:315–329. https://doi.org/10.1093/bja/aes264
Sahu S, Nag DS, Swain A, Samaddar DP (2017) Biochemical changes in the injured brain. World J Biol Chem 8:21–31. https://doi.org/10.4331/wjbc.v8.i1.21
Spetzler RF, McDougall CG, Zabramski JM, Albuquerque FC, Hills NK, Russin JJ, Partovi S, Nakaji P, Wallace RC (2015) The Barrow ruptured aneurysm trial: 6-year results. J Neurosurg 123:1–9. https://doi.org/10.3171/2014.9.JNS141749
Sugimoto K, Shirao S, Koizumi H, Inoue T, Oka F, Maruta Y, Suehiro E, Sadahiro H, Oku T, Yoneda H, Ishihara H, Nomura S, Suzuki M (2016) Continuous monitoring of spreading depolarization and cerebrovascular autoregulation after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 25:e171–e177. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.07.007
Takenaka KV, Sakai N, Murase S, Kuroda T, Okumura A, Sawada M (2000) Elevated transferrin concentration in cerebral spinal fluid after subarachnoid hemorrhage. Neurol Res 22:797–801
Tasneem N, Samaniego EA, Pieper C, Leira EC, Adams HP, Hasan D, Ortega-Gutierrez S (2017) Brain multimodality monitoring: a new tool in neurocritical care of comatose patients. Crit Care Res Pract 2017:6097265. https://doi.org/10.1155/2017/6097265
Vergouwen MD, Frijns CJ, Roos YB, Rinkel GJ, Baas F, Vermeulen M (2004) Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 35:1280–1283. https://doi.org/10.1161/01.STR.0000128707.48644.7e
Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos YB (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41:2391–2395. https://doi.org/10.1161/STROKEAHA.110.589275
Washington CW, Zipfel GJ, Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid H (2011) Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Neurocrit Care 15:312–317. https://doi.org/10.1007/s12028-011-9594-8
Conflict of interest
RJ, DP, MDO, PD, KHW, and US are the members of the Editorial Board of Neurosurgical Review.
Ethical approval is not required for this type of study.
Informed consent is not required for this type of study.
Electronic supplementary material
About this article
Cite this article
Jabbarli, R., Pierscianek, D., Darkwah Oppong, M. et al. Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review. Neurosurg Rev 43, 825–833 (2020). https://doi.org/10.1007/s10143-018-1037-y